Form 8-K Summary
Registrant: Haymaker Acquisition Corp. III, the SPAC associated with the Biote transaction context. The filing was reported on November 15, 2021, with the signature dated November 18, 2021. It addresses non-reliance on previously issued financial statements under Item 4.02.
Business Context and Reporting Period
The audit committee determined that certain previously filed financial statements should no longer be relied upon because all Class A common stock was reclassified as temporary equity. Affected filings include the audited balance sheet as of March 4, 2021 and unaudited financial statements as of March 31, 2021 and June 30, 2021.
Financial and Control Matters
- The filing does not provide revised revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
- The accounting issue involved the classification of redeemable Class A common stock as temporary equity.
- The company also identified the need for proper accounting for warrants as liabilities.
- Management concluded that disclosure controls and procedures were not effective as of September 30, 2021 because of a material weakness involving complex financial instruments.
Material Changes Versus Prior Period
The company will restate the affected financial statements in Note 2 to its Form 10-Q for the period ended September 30, 2021. The filing text does not provide the quantitative effect of the restatements.
Outlook, Risks, and Unusual Items
- Management performed additional analysis to support preparation of the September 30, 2021 interim financial statements under U.S. GAAP.
- Management stated that the financial statements expected to be included in the September 30, 2021 Form 10-Q would fairly present the company’s financial position, results of operations, and cash flows in all material respects.
- The material weakness creates reporting and financial-statement risk until remediation is completed.
- The filing does not describe a remediation timetable or specific corrective actions beyond additional analysis and restatement.
Investor Verification Points
- Verify the quantitative impact of the temporary-equity reclassification and warrant-liability accounting in the subsequent Form 10-Q.
- Review the restated March 4, March 31, and June 30, 2021 financial statements and related disclosures.
- Assess whether the September 30, 2021 Form 10-Q reports effective disclosure controls or continuing material weaknesses.
- Confirm any effect on reported equity, liabilities, earnings, cash flows, and the SPAC transaction or redemption mechanics.